from Reuters: Business News http://ift.tt/2EkCoQu
Monday, 29 January 2018
How Sanofi's setback could lead to better dengue vaccines
CHICAGO (Reuters) - New dengue vaccines being developed by Takeda Pharmaceuticals Co Ltd and U.S. government scientists are poised to provide a safer alternative to Sanofi's Dengvaxia, according to vaccine experts, because they already take into account some of the issues that sidelined the product last year.
from Reuters: Business News http://ift.tt/2EkCoQu
from Reuters: Business News http://ift.tt/2EkCoQu
Subscribe to:
Post Comments (Atom)
2 jobs with career security and 2 that are riskier
Healthcare work is more secure, as it's less affected by changes to the job market. Reza Estakhrian/Getty Images Healthcare workers and ...
-
Student-loan borrowers said they're worried about higher payments without the SAVE plan. Aaron Hawkins/Getty Images/iStockphoto Tru...
-
Big Tech is emerging a winner in the new H-1B system, while early-stage startups could lose out. Matthias Balk/nirat/Getty/Getty Images ...
-
Healthcare costs will change for Americans in 2026. Reza Estakhrian/Getty Images Health insurance costs are expected to rise for Americ...
No comments:
Post a Comment